Cannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT

Cannabidiol as a treatment for patients who are clinically at high risk of developing psychosis: learnings from the CANTOP-RCT

Background There are no licensed pharmacological treatments for people who are at clinical high risk of developing psychosis. Although psychological interventions are well tolerated, they do not appear to reduce the risk of later transition to psychosis. Clinically high-risk people commonly experien...

Full description

Saved in:
Bibliographic Details
Main Authors: Sagnik Bhattacharyya, Cathy Davies, Ben Carter, Philip McGuire, Michael Brammer, Paolo Fusar-Poli, Matthew Broome, Stuart Watson, Jesus Perez, Alison Yung
Format: Article
Language:English
Published: NIHR Journals Library 2025-03-01
Series:Efficacy and Mechanism Evaluation
Subjects:
clinical high-risk state
psychosis
cannabidiol
rct
neuroimaging
Online Access:https://doi.org/10.3310/YNFH9826
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.3310/YNFH9826

Similar Items